Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
about
The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancerAntitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene.Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primatesConcomitant quantification of targeted drug delivery and biological response in individual cellsArmed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).Prospects and RISC score of viral gene therapy for sarcoma.Transductional targeting of adenovirus vectors for gene therapyGene therapy for malignant glioma.Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA RegulationSynergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo.The effect of the PQ1 anti-breast cancer agent on normal tissuesRadiogenic therapy: novel approaches for enhancing tumor radiosensitivity.Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.Herpes simplex virus 1 (HSV-1) for cancer treatment.Do there exist synergistic antitumor effects by coexpression of herpes simplex virus thymidine kinase with cytokine genes on human gastric cancer cell line SGC7901?The roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapyTherapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?Specifically targeted gene therapy for small-cell lung cancer.Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir.Gap junctions and connexins as therapeutic targets in cancer.Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamolHarnessing mesenchymal stem cell homing as an anticancer therapy.Gene Delivery in Neuro-Oncology.Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity.Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells.Development of an inducible suicide gene system based on human caspase 8.Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901.An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.Combined delivery of temozolomide and the thymidine kinase gene for treatment of glioblastoma.Gap Junction Enhancer Potentiates Cytotoxicity of Cisplatin in Breast Cancer Cells.Evaluation of the spatial diffusion of methylene blue injected in vivo by bronchoscopy into non-small cell lung carcinoma.Gene therapy of liver cancer.In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.RNA Structure Design Improves Activity and Specificity of trans-Splicing-Triggered Cell Death in a Suicide Gene Therapy Approach.
P2860
Q30689378-BD29CC9A-2452-488B-B990-984C2DCA6CFCQ33597745-656E7568-95A3-46B7-BA6E-6326391D3944Q33713075-FE24F5E1-E071-41DE-BC2D-DD0C965309F2Q34129721-FCCAFF26-DBDC-413A-94CC-4F60E1DCD673Q35043106-4124850C-4ED0-4587-B0DE-BD855AA06AE7Q35176800-F349D972-A002-44E1-8177-F65949D21BDEQ35498592-F60A17EC-9282-4457-8A74-35CFF97FB0AEQ35594072-6DA22B3C-37ED-4045-A83E-83EA09B74818Q35609035-7423A701-AD3B-4A63-BF29-06F7175ACB0BQ35673628-9C9F38CD-9990-4779-A507-C3E70A2AA6E1Q35865503-DECFEC28-F2A3-4162-A4AE-07D3B6D45245Q35866418-A71DAAE0-374D-4D22-BDD0-9BAFF28CAB9BQ36191977-8D79658D-4F79-45A0-95BE-5C0B6A6B7228Q36200146-A8EB2981-4346-40DE-B976-4A5D61C92655Q36422849-70B062AE-1AEA-48CB-830C-7F5EDE89D73CQ36444443-2E41F5B9-6517-4D8B-974F-B083B2193636Q36474568-A3800F90-B8D1-4E6D-90C3-AF1C72D2D1C5Q36618550-0A749352-34EA-4A32-8B34-983D84EA8C20Q36640056-7CAC33C8-2A8D-4372-ADB9-7211B2F56F7BQ36856302-186D91EC-1F53-4589-91FA-1D02670B115AQ36913900-BD896084-8621-465B-91F3-41F2D073729DQ37449030-4140402B-92C2-4A34-AAA9-CBDA34D1EFDCQ37684212-19580D00-1255-4117-A917-CE2076D2A89BQ37743527-95E076EC-CAB3-40D6-AC3C-EB20FC1CCA4DQ38798857-C8709563-3F5F-4895-BAF4-67D28C00A0C2Q38857484-44468DC8-F5B2-4B63-A91F-644479B9F35CQ40060078-92B92C22-BB6C-4481-AFAD-0AB51B079E43Q40394516-6DF784E0-8802-4C20-BF96-68D0F3FF36DBQ40416863-62F915C0-666E-48DC-B5FD-126F199CD67CQ40450767-F83EC03C-5B38-4F06-BD9D-0A1159862B20Q40541147-90A128A2-10CF-4D65-B7C4-E2BD37EC9407Q40598664-3B62226C-7DD7-464F-9116-3426F52EBAE6Q40657080-0FA4D0E7-85A8-4D99-AD21-247E6C49344FQ42131038-9BD1D3C2-999D-4305-BCB4-6645AD95A832Q42497924-A07D64CB-E020-464F-8B4E-26DB314573D2Q42726362-474ABC4B-3C9B-4B77-BEBA-C7F13C2F2F4FQ45297004-BE936F02-EC39-4650-B262-49F9D76ABE90Q45883534-06F86A4D-0E44-4CA1-9888-4D38217112CFQ54112053-FD50B036-B75E-4589-BFE5-3F8680A274CAQ54965958-E7B0A590-CF3C-44E6-8542-F6937A5F831F
P2860
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@ast
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@en
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@nl
type
label
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@ast
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@en
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@nl
prefLabel
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@ast
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@en
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@nl
P2093
P356
P1433
P1476
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
@en
P2093
Erik F J de Vries
Geke A P Hospers
Ingrid J van Dillen
Nanno H Mulder
Willem Vaalburg
P304
P356
10.2174/1566523023347733
P407
P577
2002-09-01T00:00:00Z